Open AccessOptimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
Author(s) -
M V Padma Srivastava
Publication year - 2010
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.61270
Subject(s) - medicine , antithrombotic , clopidogrel , aspirin , regimen , stroke (engine) , secondary prevention , randomized controlled trial , platelet aggregation inhibitor , ticlopidine , intensive care medicine , mechanical engineering , engineering
Role of antiplatelet therapy in secondary stroke prevention is of major significance. Antiplatelet agents predominantly in use are aspirin, clopidogrel, and combination regimes. The review focuses on the optimization of antiplatelet regimen based on evidence obtained from randomized-controlled trials, on different antiplatelet regimes and the risk assessment that may be unique to each patient.